Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Susceptibility-Guided Therapy for Helicobacter Pylori Infection
NCT05250050Phase 4Withdrawn
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Mar 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole, bismuth subcitrate, amoxicillin, tetracycline, clarithromycin in Helicobacter pylori infection, sponsored by Zhongshan Hospital, Fudan University. Planned start Mar 2022; status: withdrawn.
02
Drugs
esomeprazolebismuth subcitrateamoxicillintetracyclineclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05250050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05250050.